ticagrelor 60 mg/1
ticagrelor · TABLET · Radha Pharmaceuticals INC
ticagrelor is a tablet containing ticagrelor at 60 mg/1, taken oral. Manufactured by Radha Pharmaceuticals INC.
Key Facts
- Brand Name
- ticagrelor
- Generic Name
- ticagrelor
- NDC Code (Product)
77771-521- Manufacturer
- Radha Pharmaceuticals INC
- Strength
- 60 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- ANDA218962
- Drug Class
- P2Y12 Platelet Inhibitor [EPC]
- Marketing Start
- 10/09/2025
Recall History
AstraZeneca Pharmaceuticals, LP
Presence of Foriegn Tablets/Capsules: customer complaint that an 8-count professional sample bottle labeled as BRILINTA 90 mg tablets contained 5 ZURAMPIC 200 mg tablets, in addition to the expected 8 BRILINTA tablets.
Side Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is ticagrelor used for?
ticagrelor contains ticagrelor. It is a tablet taken oral. Consult your doctor for specific uses.
Is ticagrelor a controlled substance?
ticagrelor is not classified as a controlled substance by the DEA.
What is the generic name for ticagrelor?
The generic name for ticagrelor is ticagrelor. There are 10 other brand versions of ticagrelor.
What is the NDC code for ticagrelor 60 mg/1?
The NDC (National Drug Code) for ticagrelor 60 mg/1 is 77771-521, listed by Radha Pharmaceuticals INC.